SAGE Cervical Cancer Screening Now Starts at Age 21

SAGE Expands Cervical Cancer Screening Eligibility to Age 21

Minnesota’s SAGE Screening Program has updated its eligibility guidelines, making cervical cancer screening and related diagnostic services available to eligible patients beginning at age 21.

Previously, younger women could face financial barriers to receiving this important preventive care. The expanded eligibility gives more uninsured and underinsured Minnesotans access to screening that can find abnormal cervical cells before they develop into cancer.

What Is the SAGE Screening Program?

SAGE is Minnesota’s breast and cervical cancer screening program. It helps eligible patients receive free screening and diagnostic services when they do not have insurance—or when their insurance does not adequately cover the care they need.

Under the updated 2026 guidelines, patients must meet the program’s age, insurance, residency, and income requirements.

For cervical cancer screening and diagnostic services, patients may qualify if they:

  • Are between 21 and 64 years old
  • Are uninsured or meet SAGE’s definition of underinsured
  • Meet the program’s residency requirements
  • Have a household income at or below 250% of the federal poverty level

SAGE considers several types of coverage to be underinsured, including some commercial insurance plans, MinnesotaCare, Medicaid plans with a spenddown or copay, and Medicare Part A only. People with Medicaid without a copay or spenddown, Medicare Part B, Medicare Advantage, or a Medicare supplement generally do not qualify.

No income documentation is required. SAGE asks patients to provide a current or recent estimate of their household income.

You can review the complete requirements in the Minnesota Department of Health’s 2026 SAGE Eligibility Guidelines.

When Should Cervical Cancer Screening Begin?

For women and other people with a cervix who are at average risk, the current U.S. Preventive Services Task Force recommendation is to begin screening at age 21.

The general screening schedule is:

Ages 21–29

A Pap test is generally recommended every three years when results are normal.

A Pap test examines cells collected from the cervix for abnormal changes that could eventually become cancer. Screening does not need to begin before age 21 simply because someone has become sexually active.

Ages 30–65

Patients generally have three screening options:

  • A Pap test alone every three years
  • A high-risk HPV test alone every five years
  • A combined Pap and HPV test, called co-testing, every five years

The best option may depend on the tests available, previous results, medical history, and the patient’s preferences.

After Age 65

Many women can stop routine cervical cancer screening after age 65 if they have had adequate normal screening and are not at increased risk. Women who have not been screened regularly may need to continue beyond age 65.

The U.S. Preventive Services Task Force provides additional information about screening ages and intervals.

Why Do Some Guidelines Say Screening Starts at Age 25?

Patients may encounter different recommendations online. The American Cancer Society recommends beginning routine cervical cancer screening at age 25 for people at average risk, while the U.S. Preventive Services Task Force and several other professional guidelines begin at age 21.

SAGE’s new eligibility beginning at age 21 allows eligible patients to follow the age-21 screening recommendation. Your healthcare provider can help you decide when to begin based on the guideline being followed and your individual medical history.

A Pap Test Is Usually Not an Annual Test

Beginning screening at age 21 does not mean that most women need a Pap test every year. When results are normal, screening every three years is usually appropriate for patients ages 21–29.

Testing too frequently can lead to unnecessary follow-up procedures for cell changes that may have gone away on their own. However, the recommended screening interval should not be confused with how often someone should receive regular primary or women’s healthcare.

Who May Need a Different Screening Schedule?

The routine schedule is intended for people at average risk. More frequent or continued screening may be recommended for someone who:

  • Has previously had an abnormal Pap or HPV test
  • Has a history of cervical precancer or cervical cancer
  • Has HIV or another condition that weakens the immune system
  • Takes medication that suppresses the immune system
  • Was exposed to diethylstilbestrol, or DES, before birth
  • Has not been screened regularly
  • Had a hysterectomy but still has a cervix

People who have had their cervix completely removed generally do not need routine cervical cancer screening unless they have a history of serious cervical precancer or cancer.

HPV vaccination greatly reduces the risk of cervical cancer, but vaccinated patients should still follow the screening schedule recommended for them.

Screening Is Different From Evaluating Symptoms

Screening recommendations apply to people who do not have symptoms. Do not wait for your next routine screening if you experience:

  • Bleeding between periods
  • Bleeding after sex
  • Bleeding after menopause
  • Unusual vaginal discharge
  • Persistent pelvic pain
  • Pain during sex

These symptoms do not necessarily mean that someone has cervical cancer, but they should be evaluated by a healthcare provider.

Cervical Cancer Is Often Preventable

Nearly all cervical cancers are associated with persistent infection from certain high-risk types of human papillomavirus, or HPV. Screening can find precancerous changes early, when they can often be treated before cancer develops.

The most important step is not waiting until symptoms appear. Talk with a healthcare provider about when you were last screened and which test is appropriate for you.

Schedule a SAGE Screening at Aslan Health

Aslan Health participates in Minnesota’s SAGE Screening Program and can help determine whether you qualify under the updated guidelines. Eligible patients may receive cervical cancer screening and necessary diagnostic services through SAGE.

To learn more or schedule an appointment, call Aslan Health at 320-297-6800 or schedule online at aslanclinic.com.

If you are unsure whether you qualify, please contact us. Our team can review the requirements with you and help you take the next step.